Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.
2.
3.

The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.

van Luijt PA, Heijnsdijk EA, Fracheboud J, Overbeek LI, Broeders MJ, Wesseling J, den Heeten GJ, de Koning HJ.

Breast Cancer Res. 2016 May 10;18(1):47. doi: 10.1186/s13058-016-0705-5.

4.

Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.

Ringberg A, Andersson I, Aspegren K, Linell F.

Eur J Surg Oncol. 1991 Oct;17(5):466-76.

PMID:
1657650
5.

Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.

Lynge E, Ponti A, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Frigerio A, Kawai M, Scharpantgen A, Broeders M, Hofvind S, Vidal C, Ederra M, Salas D, Bulliard JL, Tomatis M, Kerlikowske K, Taplin S; ICSN DCIS Working group.

Eur J Cancer. 2014 Jan;50(1):185-92. doi: 10.1016/j.ejca.2013.08.013. Epub 2013 Sep 13.

6.

Breast carcinoma in situ: risk factors and screening patterns.

Claus EB, Stowe M, Carter D.

J Natl Cancer Inst. 2001 Dec 5;93(23):1811-7.

PMID:
11734598
7.

Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.

Ringberg A, Palmer B, Linell F, Rychterova V, Ljungberg O.

Eur J Surg Oncol. 1991 Feb;17(1):20-9.

PMID:
1847343
8.

Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.

Duffy SW, Dibden A, Michalopoulos D, Offman J, Parmar D, Jenkins J, Collins B, Robson T, Scorfield S, Green K, Hall C, Liao XH, Ryan M, Johnson F, Stevens G, Kearins O, Sellars S, Patnick J.

Lancet Oncol. 2016 Jan;17(1):109-14. doi: 10.1016/S1470-2045(15)00446-5. Epub 2015 Dec 5. Erratum in: Lancet Oncol. 2016 Feb;17(2):e46.

9.

Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.

Román M, Rué M, Sala M, Ascunce N, Baré M, Baroja A, De la Vega M, Galcerán J, Natal C, Salas D, Sánchez-Jacob M, Zubizarreta R, Castells X; Cumulative False Positive Risk Group.

PLoS One. 2013 Dec 23;8(12):e83121. doi: 10.1371/journal.pone.0083121. eCollection 2013.

10.

Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).

Groen EJ, Elshof LE, Visser LL, Rutgers EJT, Winter-Warnars HAO, Lips EH, Wesseling J.

Breast. 2017 Feb;31:274-283. doi: 10.1016/j.breast.2016.09.001. Epub 2016 Sep 23. Review.

11.

Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?

Foster MC, Helvie MA, Gregory NE, Rebner M, Nees AV, Paramagul C.

Radiology. 2004 Jun;231(3):813-9. Epub 2004 Apr 22.

PMID:
15105449
12.

Is there a low-grade precursor pathway in breast cancer?

King TA, Sakr RA, Muhsen S, Andrade VP, Giri D, Van Zee KJ, Morrow M.

Ann Surg Oncol. 2012 Apr;19(4):1115-21. doi: 10.1245/s10434-011-2053-0. Epub 2011 Sep 21.

PMID:
21935747
13.

Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.

Li CI, Daling JR, Malone KE.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):1008-11.

14.

The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?

Bagaria SP, Shamonki J, Kinnaird M, Ray PS, Giuliano AE.

Ann Surg Oncol. 2011 Jul;18(7):1845-51. doi: 10.1245/s10434-011-1563-0. Epub 2011 Feb 2.

PMID:
21287281
15.

Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors.

Chuwa EW, Tan VH, Tan PH, Yong WS, Ho GH, Wong CY.

ANZ J Surg. 2008 Jan-Feb;78(1-2):42-8. doi: 10.1111/j.1445-2197.2007.04354.x.

PMID:
18199204
16.

Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.

Jørgensen KJ, Gøtzsche PC, Kalager M, Zahl PH.

Ann Intern Med. 2017 Mar 7;166(5):313-323. doi: 10.7326/M16-0270. Epub 2017 Jan 10.

PMID:
28114661
17.

Utility of four-quadrant random sections in mastectomy specimens.

Gupta D, Nath M, Layfield LJ.

Breast J. 2003 Jul-Aug;9(4):307-11.

PMID:
12846866
18.

Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.

Sakorafas GH, Tsiotou AG.

Cancer Treat Rev. 2000 Apr;26(2):103-25. Review.

PMID:
10772968
20.

Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?

Punglia RS, Schnitt SJ, Weeks JC.

J Natl Cancer Inst. 2013 Oct 16;105(20):1527-33. doi: 10.1093/jnci/djt256. Epub 2013 Sep 25.

PMID:
24068769

Supplemental Content

Support Center